Gynesonics Lands $21,000,000 Series D Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4edba57f-3801-40ee-868f-4c7589dff1a0&Preview=1 -
Date
2/20/2013 -
Company Name
Gynesonics -
Mailing Address
604 Fifth Avenue Redwood City, CA 94063 -
Company Description
Gynesonics is a private company that is developing a novel, minimally invasive system to treat uterine fibroid tumors, The VizAblate system. Gynesonics’ disposable, hand-held device combines ultrasound imaging to allow the gynecologist to identify fibroids with radiofrequency energy to ablate the tumor. In addition to a simple procedure for the physician, Gynesonics same-day out patient treatment should be easier for the patient and at a far lower cost for insurers. -
Website
http://www.gynesonics.com -
Transaction Type
Venture Equity -
Transaction Amount
$21,000,000 -
Transaction Round
Series D -
Proceeds Purposes
Gynesonics will use the proceeds to continue clinical and commercial development of the VizAblate(R) System, a transcervical, ultrasound-guided ablation system for the treatment of uterine fibroids. -
M&A Terms
-
Venture Investor
HBM Bioventures -
Venture Investor
Correlation Ventures -
Venture Investor
Abingworth Management -
Venture Investor
Advanced Technology Ventures -
Venture Investor
InterWest Partners
